Literature DB >> 18809734

Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.

Catherine Gelin1, Ivan Sloma, Dominique Charron, Nuala Mooney.   

Abstract

MHC class II and CD1-mediated antigen presentation on various APCs [B cells, monocytes, and dendritic cells (DC)] are subject to at least three distinct levels of regulation. The first one concerns the expression and structure of the antigen-presenting molecules; the second is based on the extracellular environment and signals of danger detected. However, a third level of regulation, which has been largely overlooked, is determined by lateral associations between antigen-presenting molecules and other proteins, their localization in specialized microdomains within the plasma membrane, and their trafficking pathways. This review focuses on features common to MHC II and CD1 molecules in their ability to activate specific T lymphocytes with the objective of addressing one basic question: What are the mechanisms regulating antigen presentation by MHC II and CD1 molecules within the same cell? Recent studies in immature DC, where MHC II and CD1 are coexpressed, suggest that the invariant chain (Ii) regulates antigen presentation by either protein. Ii could therefore favor MHC II or CD1 antigen presentation and thereby discriminate between antigens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809734     DOI: 10.1189/jlb.0308206

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  12 in total

Review 1.  Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Authors:  Richard T Sawyer; Lisa A Maier
Journal:  Biometals       Date:  2010-10-28       Impact factor: 2.949

Review 2.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

3.  Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.

Authors:  Jennifer C Bailey; Abhirami K Iyer; Gourapura J Renukaradhya; Yinling Lin; Hoa Nguyen; Randy R Brutkiewicz
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

4.  Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells.

Authors:  Takeshi Yamasaki; Gerald S Baron; Akio Suzuki; Rie Hasebe; Motohiro Horiuchi
Journal:  Virology       Date:  2014-01-15       Impact factor: 3.616

Review 5.  Inflammation, immunity, and hypertension.

Authors:  David G Harrison; Tomasz J Guzik; Heinrich E Lob; Meena S Madhur; Paul J Marvar; Salim R Thabet; Antony Vinh; Cornelia M Weyand
Journal:  Hypertension       Date:  2010-12-13       Impact factor: 10.190

Review 6.  Current advances in understanding of immunopathology of atherosclerosis.

Authors:  Colin-John Perrins; Yuri V Bobryshev
Journal:  Virchows Arch       Date:  2010-11-11       Impact factor: 4.064

7.  TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation.

Authors:  M K Newell; R P Tobin; J H Cabrera; M B Sorensen; A Huckstep; E M Villalobos-Menuey; M Burnett; E McCrea; C P Harvey; A Buddiga; A Bar-Or; M S Freedman; J Nalbantoglu; N Arbour; S S Zamvil; J P Antel
Journal:  J Leukoc Biol       Date:  2010-07-14       Impact factor: 4.962

8.  Human monocytes differentiate into dendritic cells subsets that induce anergic and regulatory T cells in sepsis.

Authors:  Valérie Faivre; Anne Claire Lukaszewicz; Arnaud Alves; Dominique Charron; Didier Payen; Alain Haziot
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

Review 9.  The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation.

Authors:  Catherine Gottschalk; Elisabeth Mettke; Christian Kurts
Journal:  Front Immunol       Date:  2015-07-28       Impact factor: 7.561

Review 10.  Exposing the Specific Roles of the Invariant Chain Isoforms in Shaping the MHC Class II Peptidome.

Authors:  Jean-Simon Fortin; Maryse Cloutier; Jacques Thibodeau
Journal:  Front Immunol       Date:  2013-12-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.